# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001493152-24-043352
Filing Date
2024-11-01
Accepted
2024-11-01 16:55:34
Documents
18
Period of Report
2024-10-25
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form8-k.htm iXBRL | 8-K | 39662
2 |  | ex3-1.htm | EX-3.1 | 886
3 |  | ex99-1.htm | EX-99.1 | 14509
4 |  | ex3-1_001.jpg | GRAPHIC | 1392294
5 |  | ex99-1_001.jpg | GRAPHIC | 20053
| Complete submission text file | 0001493152-24-043352.txt |  | 2182084

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL SCHEMA FILE | qlgn-20241025.xsd | EX-101.SCH | 3009
7 | XBRL LABEL FILE | qlgn-20241025_lab.xml | EX-101.LAB | 34240
8 | XBRL PRESENTATION FILE | qlgn-20241025_pre.xml | EX-101.PRE | 24161
21 | EXTRACTED XBRL INSTANCE DOCUMENT | form8-k_htm.xml | XML | 3808

Mailing Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011
Business Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011 (760) 918-9165
Qualigen Therapeutics, Inc. (Filer) CIK: 0001460702 (see all company filings)

EIN.: 263474527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37428 | Film No.: 241419806
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)